About Drug-Eluting Stent
Drug-eluting stents, also known as medicated coronary stents, are used to inhibit artery blockages that may occur in patients after an angioplasty surgery. A drug-eluting stent is a tiny, expandable metal mesh tube, which is covered with a pharmacologic agent (drug). Drug-eluting stents are used to treat patients that suffer from atherosclerosis that can occur because of hypertension, smoking, a sedentary lifestyle, or a high-cholesterol diet. After a patient undergoes angioplasty, there is a chance that the artery might close again because of blood clots or excessive growth of the surrounding tissues. To address this problem, drug-eluting stents are placed in the artery, preventing it from narrowing or clogging. Thus, drug-eluting stents eliminate the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels). Restenosis of an artery occurs because of the bodys natural immune response to an injury. Drug-eluting stents help in reducing the arterial blockage and ensure smooth blood flow through the arteries.
Technavios analysts forecast the global drug-eluting stent market to grow at a CAGR of 3.45% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global drug-eluting stent market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drug-eluting stent products.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavios report, Global Drug-Eluting Stent Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Abbott Laboratories
Biosensors International Group
Boston Scientific
Medtronic
Terumo Corporation
Other prominent vendors
Biotronik
Cook Medical
Envision Scientific
Lepu Medical
Meril Life Sciences
MicroPort Medical
Opto Circuits
Shandong JW Medical Systems
STENTYS
Market driver
High prevalence of atherosclerosis diseases
For a full, detailed list, view our report
Market challenge
Decline in price of drug-eluting stent
For a full, detailed list, view our report
Market trend
Increasing partnership and collaboration activities
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Drug-eluting stents: An overview
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Drugs employed in drug-eluting stents
PART 08: Geographical segmentation
Drug-eluting stent market in Americas
Drug-eluting stent market in EMEA
Drug-eluting stent market in APAC
PART 09: Key leading countries
US
China
Germany
Japan
PART 10: Market drivers
High prevalence of atherosclerosis diseases
Favorable reimbursement scenario
Reduced risk of contracting restenosis
Technological advancements
PART 11: Impact of drivers
PART 12: Market challenges
Decline in price of drug-eluting stents
Availability of alternative procedures
Preference for drugs over stents
Risk of late-stage thrombosis
PART 13: Impact of drivers and challenges
PART 14: Market trends
Increasing
PARTnership and collaboration activities
Growing popularity of hybrid procedures
Growing focus on emerging countries
PART 15: Vendor landscape
Competitive scenario
Market share analysis 2015
Key vendor analysis
Abbott Laboratories
Biosensors International
Boston Scientific
Medtronic
Terumo
Other prominent vendors
PART 16: Appendix
List of abbreviations
PART 17: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Treatment options: Percutaneous coronary intervention
Exhibit 03: Cross section of a stent
Exhibit 04: Agents used in drug-eluting stents
Exhibit 05: History of drug-eluting stent
Exhibit 06: Global drug-eluting stent market 2015-2020 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Classification of drugs used in drug-eluting stents
Exhibit 09: Segmentation of global drug-eluting stent market by geography 2015
Exhibit 10: Segmentation of global drug-eluting stent market by geography 2020
Exhibit 11: Segmentation of global drug-eluting stent market by geography 2015-2020
Exhibit 12: Drug-eluting stent market in Americas 2015-2020 ($ billions)
Exhibit 13: Drug-eluting stent market in EMEA 2015-2020 ($ billions)
Exhibit 14: Drug-eluting stent market in APAC 2015-2020 ($ billions)
Exhibit 15: Key leading countries
Exhibit 16: Market share of key leading countries in global drug-eluting stent market 2015
Exhibit 17: List of major biodegradable-coated drug-eluting stent products 2015
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: Estimated healthcare spending in BRIC countries in 2015 ($ billions)
Exhibit 21: Abbott Laboratories: Key takeaways
Exhibit 22: Biosensors International: Business segmentation by revenue 2015
Exhibit 23: Biosensors International: Key takeaways
Exhibit 24: Boston Scientific: Business segmentation by revenue 2014
Exhibit 25: Boston Scientific: Geographical segmentation by revenue 2014
Exhibit 26: Boston Scientific: Key takeaways
Exhibit 27: Medtronic: Key takeaways
Exhibit 28: Terumo: Key takeaways
